Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes

Leukemia Research

Volumn 29, Issue 1, 2005, Pages 41-46

  Alexandrakis, Michael G ^a   Passam, Freda H ^b   Pappa, Constantina A ^a   Sfiridaki, Katerina ^c   Tsirakis, George ^a   Damilakis, John ^a   Stathopoulos, Efstathios N ^a   Kyriakou, Despina S ^d  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

^c Venizelion General Hospital   (Greece)

^d UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

Angiogenesis; Angiogenin; FAB; French American British classification; International Prognostic Scoring System; IPSS; MDS; Microvessel density; Myelodysplastic syndromes; myelodysplastic syndromes; RA; RAS; refractory anemia

Indexed keywords

ANGIOGENIN; INTERLEUKIN 6;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE MARROW; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MICROVASCULATURE; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; RISK ASSESSMENT;

AGED; BONE MARROW; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RIBONUCLEASE, PANCREATIC; RISK; SURVIVAL ANALYSIS;

EID: 8444223866     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.05.002     Document Type: Article

References (37)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:1995;27-31
2. Ellis L.M., Fidler I.J. Angiogenesis and metastasis. Eur. J. Cancer. 32A:1996;2451-2460
3. Toi M., Kashitani J., Tominaya T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int. J. Cancer. 57:1993;371-374
4. Maeda K., Chung Y.S., Takatsuka S., Onoda N., Sawada T., Kato Y., et al. Tumor angiogenesis and tumor cell proliferation as prognostic indicators in gastric carcinoma. Br. J. Cancer. 72(2):1995;319-323
5. Tanigawa N., Amaya H., Matsumura M., Shimomatsuya T., Horiuchi T., Muraoka R., et al. Extent of tumor vascurarization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res. 56:1996;2671-2676
6. Padro T., Ruiz S., Biecker R., Burger H., Steins M., Kienast J., et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood. 95:2000;2637-2644
7. Pruneri G., Bertolini F., Soligo D., Carboni N., Cortelezzi A., Ferucci P.F., et al. Angiogenesis in mylelodysplastic syndromes. Br. J. Cancer. 81(8):1999;1398-1401
8. 2-microglobulin levels in patients with multiple myeloma. Ann. Hematol. 80:2001;598-601
9. Rak J., Filmus J., Kerbel R.S. Reciprocal paracrine interactions between tumor cells and endothelial cells: the "angiogenesis progression" hypothesis. Eur. J. Cancer. 32A(14):1996;2438-2450
10. Shapiro R., Strydom D.J., Olsonb K.A., Valee B.L. Isolation of angiogenin from normal human plasma. Biochemistry. 26:1987;5141-5146
11. Hu G.F., Riordan J.F. Angiogenin enhances actin acceleration of plasminogen activation. Biochem. Biophys. Res. Commun. 197:1993;682-687
12. Weiner H.L., Weiner L.H., Swain J.L. Tissue distribution and development expression of messenger RNA encoding angiogenin. Science. 237(4812):1987;280-282
13. Lyons R.M., Gentry L.E., Purchio A.F., Moses H.L. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J. Cell Biol. 110(4):1990;1361-1367
14. Hu G.F., Chang S.I., Riordan J.F., Vallee B.L. An angiogenin-binding protein from endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 88(6):1991;2227-2231
15. Olson K.A., Verselis S.J., Fett J.W. Angiogenin is regulated in vivo as an acute phase protein. Biochem. Biophys. Res. Commun. 242:1998;480-483
16. 2 hepatoma cells by mediators of the acute-phase response. Biochem. Biophys. Res. Commun. 16:1999;585-588
17. Hero Id M., Schmalzl F., Zwierzina H. Increased serum interleukin 6 levels in patients with myelodysplasic syndromes. Leuk. Res. 16:1992;585-588
18. Alexandrakis M., Coulocheri S., Xylouri I., Ganotakis E., Eliakis P., Karkavitsas N., et al. Elevated serum TNF-α concentrations are predictive of shortened survival in patients with high-risk myelodysplastic syndromes. Haematologia. 29:1998;13-24
19. Koike M., Ishiyama T., Tomoyasu S., Tsuruoka N. Spontaneous cytokine overproduction by peripheral blood mononuclear cells from patients with myelodysplastic syndromes and aplastic anemia. Leuk. Res. 19:1995;639-644
20. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Grainick H.R., et al. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51:1982;189-199
21. Greenberg P., Cox C., Le Beau M.M., Fenaux P., Morel P., Sanz G., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 89:1997;2079-2088
22. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumour angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1991;1-8
23. Vermuelen P.B., Gasparini G., Fox S.B., et al. Quantitation of angiogenesis in the solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur. J. Cancer. 32A:1996;2474-2484
24. Hartmann A., Kunz M., Kostlin S., Gillitzer R., Toksoy A., Brocker E.B., et al. Hypoxia induced up-regulation of angiogenin in human malignant melanoma. Cancer Res. 59:1999;1578-1583
25. Li D., Bell J., Brown A., Berry C.L. The observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas. J. Pathol. 172:1994;171-175
26. Choopra V., Dinh T.V., Hannigan E.V. Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer. J. Cancer Res. Clin. Oncol. 123:1997;167-172
27. Shimoyama S., Yamasaki K., Kawahara M., Kaminishi M. Increased serum angiogenin concentrations in colorectal cancer is correlated with cancer progression. Clin. Cancer Res. 5:1999;1125-1130
28. Miyake H., Hara I., Yamanaka K., Gohji K., Arakawa S., Kamidono S. Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to disease progression and recurrence. Cancer. 86:1999;316-324
29. Verstovsek S., Kantarjian H., Aguayo A., Mansouri T., Freireich E., Keating M., et al. Significance of angiogenin plasma concentrations in patients with acute myeloid leukemia and advanced myelodysplastic syndrome. Br. J. Haematol. 114:2001;290-295
30. Brunner B., Gunsilius E., Schumacher P., Zwierzina H., Gasti G., Stauder R. Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia. J. Hematother. Stem Cell Res. 11:2002;119-125
31. Aguayo A., Kantarjian H., Manshouri T., Gidel C., Estey E., Thomas D., et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood. 96:2000;2240-2245
32. Korkopoulou P., Apostolidou E., Pavlopoulos P.M., Kavantzas N., Vyniou N., Thymara I., et al. Prognostic evaluation of the microvascular network in myelodysplastic syndromes. Leukemia. 15:2001;1369-1376
33. Ribatti D., Polimeno G., Vacca A., Marzullo A., Crivellato E., Nico B., et al. Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes. Leukemia. 16:2002;1680-1684
34. Albitar M. Angiogenesis in acute myeloid leukemia and myelodysplastic syndrome. Acta Haematol. 106:2001;170-176
35. Kumar S., Fonseca R., Dispenzieri A., Lacy M.Q., Lust J.A., Wttzig T.E., et al. Bone marrow angiogenesis in multiple myeloma: effect of therapy. Br. J. Haematol. 119:2002;665-671
36. Vacca A., Ribatti D., Roncali L., Ranieri G., Serio G., Silvestris F., et al. Bone marrow angiogenesis and progression in multiple myeloma. Br. J. Haematol. 87:1994;503-508
37. Baumann H., Gauldie J. The acute phase response. Immunol. Today. 15:1994;74-80